Mark For: MURAL™ trademark registration is intended to cover the categories of biopharmaceutical active substances, namely, pharmaceutical preparations and substances for the treatment of oncological-related diseases and disorders; Biological preparations for the treatment of cancer; therapeutic proteins for use in the manufacture of pharmaceutical preparations; Engineered fusion proteins for medical diagnostic and treatment purposes, namely fusion proteins created through the use of circular permutation technology, engineered interleukins for optimizing patients' immune cellular response to prevent cancer-associated morbidity and mortality and tumor-targeted immunotherapeutic fusion proteins; Cytokine and protein based treatments for oncology-related diseases and disorders; Cytokine and protein fusions medicines having enhanced pharmacokinetics for cancer immunotherapy research and development.
Status
2023-05-01 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
Yes
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Domestic Representative
Norm J. Rich
Attorney Name
Norm J. Rich
Attorney Docket Number
029318-
Timeline
2023-04-26
Application Filed
2023-05-01
Location: NEW APPLICATION PROCESSING
2023-05-01
Status: Live/Pending
2023-05-01
Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
NORM J. RICH FOLEY & LARDNER LLP 3000 K STREET, N.W. SIXTH FLOOR WASHINGTON, DC 20007
Good, Services, and Codes
International Codes:
5
U.S. Codes:
005,006,018,044,046,051,052
International Codes:
42
U.S. Codes:
100,101
International Codes:
44
U.S. Codes:
100,101
Type Code
Type
GS0051
Biopharmaceutical active substances, namely, pharmaceutical preparations and substances for the treatment of oncological-related diseases and disorders; Biological preparations for the treatment of cancer; therapeutic proteins for use in the manufacture of pharmaceutical preparations; Engineered fusion proteins for medical diagnostic and treatment purposes, namely fusion proteins created through the use of circular permutation technology, engineered interleukins for optimizing patients' immune cellular response to prevent cancer-associated morbidity and mortality and tumor-targeted immunotherapeutic fusion proteins; Cytokine and protein based treatments for oncology-related diseases and disorders; Cytokine and protein fusions medicines having enhanced pharmacokinetics for cancer immunotherapy research and development
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
OneLook
Acronym Finder
Alkermes Pharma Ireland Limited
Application
| 